Let-7 microRNA as a potential therapeutic target with implications for immunotherapy.
MicroRNAs (miRNA) are a class of small non-coding RNA that play a major role in various cellular processes by negatively regulating gene expression. In the past decade, miRNA dysregulation has been reported to be closely linked to inflammatory diseases. The immune response modulates cancer initiation and progression; miRNAs including let-7 family members have been shown to act as key regulators of the immune responses in various diseases and cancers. Notably, the let-7 miRNA has been reported to be closely associated with immunity, specifically with Toll-like receptors that mediate cytokine expression during pathogen infection and with the regulation of various other immune effectors. Areas covered: In this review, the authors describe the discovery of let-7 as the starting point of the RNA revolution and highlight let-7 as an efficient tool for cancer and immune therapy. Expert opinion: let-7 miRNA has emerged as a key player in cancer therapy and immune responses and it has potential role as a new immunotherapeutic target. However, while there are challenges regarding miRNA delivery, the exciting emergence of personalized medicine for cancer and immunotherapy could be beneficial for the development of let-7 therapeutics.
['Gilles|Maud-Emmanuelle|ME|', 'Slack|Frank J|FJ|']
D000818:Animals D016207:Cytokines D018450:Disease Progression D006801:Humans D007167:Immunotherapy D035683:MicroRNAs D009369:Neoplasms D057285:Precision Medicine
let-7 immunotherapy miRNAs immune response RNA therapy